Pembrolizumab (Keytruda) – Cancer Immunotherapy
What is Pembrolizumab?
Pembrolizumab, known as Keytruda, is an immunotherapy drug that targets the PD-1 receptor, helping the immune system recognize and attack cancer cells. It is used in treating lung cancer, melanoma, and other malignancies.
Benefits of Pembrolizumab (Keytruda)
- Boosts immune response: Helps the body fight cancer more effectively.
- Treats multiple cancers: Approved for melanoma, lung cancer, and more.
- Less toxic than chemotherapy: Fewer side effects compared to traditional treatments.
- Long-term survival benefits: Shown to extend life expectancy in some cancers.
Pembrolizumab is administered via IV infusion, typically every 3 to 6 weeks, under medical supervision.
Norberto –
The first time I got the urges to leave a comment, but this is simply a top-notch thing you can find.
Lillian –
It’s far better than those similar products, while the price is still acceptable.